ALKS FY 2023 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.7B+49.6% YoY

Gross Profit

$1.4B84.8% margin

Operating Income

$414M24.9% margin

Net Income

$356M21.4% margin

EPS (Diluted)

$2.10

Cash Flow

Operating Cash Flow

$401M

Free Cash Flow

$353M

Stock-Based Comp.

$101M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$934M

Stockholders' Equity

$1.2B

Cash & Equivalents

$457M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.1B	+49.6%
Gross Profit	$1.4B	$894M	+57.8%
Operating Income	$414M	-$6M	+6901.1%
Net Income	$356M	-$158M	+324.8%